Age-Related Macular Degeneration (AMD) is the leading cause of legal blindness for more than 2 million Canadians over the age of 50.

There is no cure for AMD, and existing pharmaceutical and laser treatments have proven only marginally effective in slowing the disease’s progression.

Today, AMD is the leading cause of severe vision loss in North America. Moreover, its prevalence is expected to double over the next 20 years as baby boomers continue to age.

What are the types of Aged-Related Macular Degeneration (AMD)?

Age-Related Macular Degeneration (AMD) causes damage to the macula, the central part of the retina responsible for seeing details. There are two types of AMD: dry or atrophic; and wet or neo-vascular. Virtually all AMD begins in the dry form and according to the Canadian Ophthalmological Society, nine of ten (10) people with AMD suffer from dry AMD.

Who does it impact?

The likelihood of an individual developing AMD is primarily determined by genetic predisposition, ethnicity, and health. If you are Caucasian, and your parents, grandparents or siblings have had AMD, you are at a substantially increased risk of developing the disease. Many studies have asserted that those with a history of smoking are also susceptible.

Who does it impact?

The likelihood of an individual developing AMD is primarily determined by genetic predisposition, ethnicity, and health. If you are Caucasian, and your parents, grandparents or siblings have had AMD, you are at a substantially increased risk of developing the disease. Many studies have asserted that those with a history of smoking are also susceptible.

What can be done for Age-Related Macular Degeneration (AMD)?

There is no known cure. Macular degeneration treatments approved for use in the U.S. focus only on slowing the progression of the disease and, in some cases, consist of placing pharmaceutical injections directly on the retina.

Treatments with the Nova Oculus medical device are not invasive and do not involve drugs. The patented microcurrent therapy employed by the Nova Oculus medical device is as old as electricity but is comparable to a modern-day TENS device. It’s cutting-edge in both design and technology.

Nova Oculus offers the only device in the world that is clinically proven to reverse the effects of Dry AMD, restore vision, drastically improve the patient’s quality of life, and reduce healthcare costs.